ICU Medical, Inc.
ICUI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.11 | 1.34 | 0.31 | 2.90 |
| FCF Yield | 3.29% | 3.02% | -4.30% | 3.70% |
| EV / EBITDA | 119.11 | 15.22 | 22.82 | 20.25 |
| Quality | ||||
| ROIC | 2.06% | 0.22% | -0.68% | 6.11% |
| Gross Margin | 34.62% | 32.75% | 30.60% | 37.34% |
| Cash Conversion Ratio | -1.73 | -5.60 | 0.84 | 2.59 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.47% | 19.73% | 21.51% | 1.30% |
| Free Cash Flow Growth | 71.87% | 144.92% | -186.63% | 52.31% |
| Safety | ||||
| Net Debt / EBITDA | 31.03 | 5.73 | 6.59 | -2.27 |
| Interest Coverage | 0.40 | 0.22 | -0.61 | 143.64 |
| Efficiency | ||||
| Inventory Turnover | 2.66 | 2.14 | 2.27 | 2.84 |
| Cash Conversion Cycle | 133.40 | 163.81 | 146.25 | 121.90 |